Feraccru® Real World Effectiveness Study in Hospital Practice ( FRESH )
NCT03247816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59
Last updated 2020-10-23
Summary
The aim of the study is to understand the early experiences of Feraccru® in patients with inflammatory bowel disease (IBD) and iron deficiency anaemia (IDA) in the UK, including treatment effectiveness, patterns of use and tolerability.
Conditions
- Anemia, Iron Deficiency
- Inflammatory Bowel Diseases
Sponsors & Collaborators
-
Shield Therapeutics
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-08-14
- Primary Completion
- 2018-03-01
- Completion
- 2018-10-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy
NCT01428843 ·Status: TERMINATED ·Phase: PHASE3
-
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
NCT00882414 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial Comparing the Incidence of Hypophosphatemia in Relation to Treatment With Iron Isomaltoside and Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia Due to Inflammatory Bowel Disease
NCT03466983 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue
NCT02517151 ·Status: UNKNOWN ·Phase: PHASE2
-
Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease
NCT05456932 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial of Iron Replacement in Patients With Iron Deficiency.
NCT01067547 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate
NCT01991314 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Versus Intravenous Iron in IBD Patients With Anti-inflammatory Therapy.
NCT05581420 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis (AEGIS-1)
NCT01340872 ·Status: COMPLETED ·Phase: PHASE3
-
Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
NCT01017614 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD
NCT02774057 ·Status: UNKNOWN ·Phase: PHASE4
-
To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis
NCT03412682 ·Status: COMPLETED ·Phase: PHASE3
-
Sucrosomial Iron vs. Oral Iron Sulfate for the Treatment of Iron Deficiency Anemia in Patients With Ulcerative Colitis
NCT05225545 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Observational Study: IBD Patients With Restless-legs-syndrome and Iron Deficiency Syndrome
NCT03457571 ·Status: COMPLETED
-
Retrospective Data Analysis in Crohn's Disease
NCT01363427 ·Status: COMPLETED
-
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
NCT00152841 ·Status: TERMINATED ·Phase: PHASE2
-
Anemia in Inflammatory Bowel Disease
NCT02760940 ·Status: UNKNOWN ·Phase: PHASE4
-
Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study
NCT03772145 ·Status: TERMINATED
-
An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)
NCT01759264 ·Status: COMPLETED
-
Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2)
NCT01352221 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
NCT02738125 ·Status: COMPLETED
-
Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
NCT00643071 ·Status: COMPLETED ·Phase: PHASE3
-
PRognOstiC valuE of rEd Density in Ulcerative Colitis
NCT04408703 ·Status: COMPLETED
-
A Pilot Study of FFP104 in Subjects With Crohn's Disease
NCT02465944 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects With Active Inflammatory Bowel Disease
NCT02790281 ·Status: COMPLETED